Table 5 Rates of adverse outcomes
| Â | Control group | PCT/Pyuria group | Odds ratio | 95% CI | P value a |
|---|---|---|---|---|---|
All patients (intention-to-treat) | (n = 64) | (n = 61) |  |  |  |
 Recurrence | 14/63 (22%) | 15/59 (25%) | 1.19 | 0.52–2.75 | 0.68 |
 Rehospitalization | 17/63 (27%) | 15/59 (25%) | 0.92 | 0.41–2.07 | 0.85 |
 Death | 4/63 (6%) | 1/59 (2%) | 0.25 | 0.03–2.30 | 0.22 |
Per-protocol population | (n = 52) | (n = 44) |  |  |  |
 Recurrence | 11/52 (21%) | 14/44 (32%) | 1.74 | 0.69–4.36 | 0.24 |
 Rehospitalization | 13/52 (35%) | 13/44 (41%) | 1.26 | 0.51–3.10 | 0.62 |
 Death | 1/52 (2%) | 0 |  |  |  |
Inpatients | (n = 45) | (n = 45) |  |  |  |
 Recurrence | 11 (25%) | 13 (30%) | 1.26 | 0.49–3.22 | 0.63 |
 Rehospitalization | 15 (34%) | 13 (30%) | 0.81 | 0.28–0.96 | 0.65 |
Uncomplicated simple UTI | (n = 6) | (n = 2) |  |  |  |
 Recurrence | 1/6 (17%) | 1/2 (50%) | 5.00 | 0.15–166.59 | 0.37 |
 Rehospitalization | 1/6 (17%) | 1/2 (50%) | 5.00 | 0.15–166.59 | 0.37 |
Complicated simple UTI | (n = 12) | (n = 16) |  |  |  |
 Recurrence | 3/11 (27%) | 6/16 (38%) | 1.60 | 0.30–8.49 | 0.58 |
 Rehospitalization | 2/11 (18%) | 6/16 (38%) | 2.70 | 0.43–16.94 | 0.29 |
Uncomplicated febrile UTI/pyelonephritis | (n = 8) | (n = 9) |  |  |  |
 Recurrence | 1/8 (13%) | 2/8 (25%) | 2.33 | 0.17–32.58 | 0.53 |
 Rehospitalization | 2/8 (25%) | 1/8 (13%) | 0.43 | 0.03–5.98 | 0.53 |
Complicated febrile UTI/pyelonephritis | (n = 34) | (n = 33) |  |  |  |
 Recurrence | 8/34 (24%) | 6/32 (19%) | 0.75 | 0.23–2.47 | 0.64 |
 Rehospitalization | 11/34 (32%) | 7/32 (22%) | 0.59 | 0.19–1.77 | 0.34 |